
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.950 | 1.950 | 0.000 |
Shares | 98.050 | 98.050 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.183 | 19.606 |
Price to Book | 4.568 | 3.867 |
Price to Sales | 1.771 | 2.210 |
Price to Cash Flow | 17.384 | 14.698 |
Dividend Yield | 1.380 | 1.499 |
5 Years Earnings Growth | 10.356 | 9.831 |
Number of long holdings: 76
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 7.82 | 735.19 | +0.36% | |
UnitedHealth | US91324P1021 | 5.30 | 308.80 | -0.35% | |
Novo Nordisk B | DK0062498333 | 4.91 | 358.5 | -1.84% | |
Thermo Fisher Scientific | US8835561023 | 3.95 | 487.53 | -1.05% | |
AstraZeneca | GB0009895292 | 3.57 | 11,904.0 | +0.46% | |
McKesson | US58155Q1031 | 2.92 | 691.62 | +0.73% | |
Boston Scientific | US1011371077 | 2.91 | 106.66 | +1.10% | |
Sanofi | FR0000120578 | 2.83 | 84.51 | -0.21% | |
Roche Holding Participation | CH0012032048 | 2.61 | 262.00 | +0.69% | |
Merck&Co | US58933Y1055 | 2.53 | 85.48 | +1.62% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Belfius Equities Robotics Innova | 1.67B | 10.60 | 16.41 | 14.95 | ||
Belfius Equities Robotics InnovaL | 1.7B | -11.78 | 3.12 | 12.49 | ||
Belfius Equities Robotics Innovat | 1.67B | 10.60 | 16.42 | 14.96 | ||
Belfius Equities Global Health CarL | 659.57M | 2.74 | -0.14 | 5.32 | ||
Belfius Equities Global Health Care | 692.86M | -4.79 | -0.89 | 4.04 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review